Translocator protein (TSPO): the new story of the old protein in neuroinflammation

키워드

참고문헌 (74)

1. Wallace DC, "Mitochondria and cancer", Nat Rev Cancer, 12, pp.685~ (2012)
2. Green DR, "Mitochondria and the autophagy–inflammation–cell death axis in organismal aging", Science, 333, pp.1109~1112 (2011)
3. Chen H, "Mitochondrial dynamics–fusion, fission, movement, and mitophagy–in neurodegenerative diseases", Hum Mol Genet, 18, pp.R169~R176 (2009)
4. Pfanner N, "Mitochondrial proteins : from biogenesis to functional networks", Nat Rev Mol Cell Biol, 20, pp.267~284 (2019)
5. Braestrup C, "High densities of benzodiazepine receptors in human cortical areas", Nature, 269, pp.702~704 (1977)
6. Papadopoulos V, "Structure and function of the peripheral-type benzodiazepine receptor in steroidogenic cells", Proc Soc Exp Biol Med, 217, pp.130~142 (1998)
7. Azarashvili T, "High-affinity peripheral benzodiazepine receptor ligand, PK11195, regulates protein phosphorylation in rat brain mitochondria under control of Ca2+", J Neurochem, 94, pp.1054~1062 (2005)
8. Hirsch JD, "Mitochondrial benzodiazepine receptors mediate inhibition of mitochondrial respiratory control", Mol Pharm, 35, pp.157~163 (1989)
9. Hirsch T, "PK11195, a ligand of the mitochondrial benzodiazepine receptor, facilitates the induction of apoptosis and reverses Bcl-2-mediated cytoprotection", Exp Cell Res, 241, pp.426~434 (1998)
10. Lee D, "Effects of peripheral benzodiazepine receptor ligands on proliferation and differentiation of human mesenchymal stem cells", J Cell Physiol, 198, pp.91~99 (2004)
11. Kim T, "Translocator protein(TSPO)ligands for the diagnosis or treatment of neurodegenerative diseases : A patent review(2010–2015; part 1)", Expert Opin Ther Pat, 26, pp.1325~1351 (2016)
12. Fan J, "Structural and functional evolution of the translocator protein(18 kDa)", Curr Mol Med, 12, pp.369~386 (2012)
13. Yeliseev AA, "A mammalian mitochondrial drug receptor functions as a bacterial"oxygen"sensor", Proc Natl Acad Sci U S A, 94, pp.5101~5106 (1997)
14. Chapalain A, "Bacterial ortholog of mammalian translocator protein(TSPO)with virulence regulating activity", PLoS One, 4, pp.e6096~ (2009)
15. Riond J, "Expression and pharmacological characterization of the human peripheraltype benzodiazepine receptor in yeast", Eur J Pharmacol, 208, pp.307~312 (1991)
16. Fan J, "Translocator protein 2 is involved in cholesterol redistribution during erythropoiesis", J Biol Chem, 284, pp.30484~30497 (2009)
17. Li F, "Crystal structures of translocator protein(TSPO)and mutant mimic of a human polymorphism", Science, 347, pp.555~558 (2015)
18. Jaremko Ł, "Structure of the mitochondrial translocator protein in complex with a diagnostic ligand", Science, 343, pp.1363~1366 (2014)
19. Guo Y, "Structure and activity of tryptophan-rich TSPO proteins", Science, 347, pp.551~555 (2015)
20. Veenman L, "Tetrapyrroles as endogenous TSPO ligands in eukaryotes and prokaryotes : Comparisons with synthetic ligands", Int J Mol Sci, 17, pp.880~ (2016)
21. Owen DR, "An 18-kDa translocator protein(TSPO)polymorphism explains differences in binding affinity of the PET radioligand PBR28", J Cereb Blood Flow Metab, 32, pp.1~5 (2012)
22. Toor JS, "Rep Dev Toxicol", pp.1111~1121 (2017), Elsevier
23. Papadopoulos V, "The peripheral-type benzodiazepine receptor is functionally linked to Leydig cell steroidogenesis", J Bioll Chem, 265, pp.3772~3779 (1990)
24. Chung J-Y, "Drug ligand-induced activation of translocator protein(TSPO)stimulates steroid production by aged brown Norway rat Leydig cells", Endocrinology, 154, pp.2156~2165 (2013)
25. Papadopoulos V, "Targeted disruption of the peripheral-type benzodiazepine receptor gene inhibits steroidogenesis in the R2C Leydig tumor cell line", J Biol Chem, 272, pp.32129~32135 (1997)
26. Hauet T, "Peripheral-type benzodiazepine receptor-mediated action of steroidogenic acute regulatory protein on cholesterol entry into leydig cell mitochondria", Mol Endocrinol, 19, pp.540~554 (2005)
27. McEnery MW, "Isolation of the mitochondrial benzodiazepine receptor : association with the voltage-dependent anion channel and the adenine nucleotide carrier", Proc Natl Acad Sci U S A, 89, pp.3170~3174 (1992)
28. Büki A, "Cytochrome c release and caspase activation in traumatic axonal injury", J Neurosci, 20, pp.2825~2834 (2000)
29. Lemasters JJ, "Mitochondrial calcium and the permeability transition in cell death", Biochim Biophys Acta Bioenerg, 1787, pp.1395~1401 (2009)
30. Azarashvili T, "Combined effect of G3139 and TSPO ligands on Ca2+-induced permeability transition in rat brain mitochondria", Arch Biochem Biophys, 587, pp.70~77 (2015)
31. Shoshan-Barmatz V, "VDAC1 and the TSPO : Expression, Interactions, and Associated Functions in Health and Disease States", Int J Mol Sci, 20, pp.3348~ (2019)
32. Selvaraj V, "The changing landscape in translocator protein(TSPO)function", Trends Endocrinol Metab, 26, pp.341~348 (2015)
33. Kim S, "Tanycytic TSPO inhibition induces lipophagy to regulate lipid metabolism and improve energy balance", Autophagy (2019)
34. 이지원, "Systematic Analysis of Translocator Protein 18 kDa (TSPO) Ligands on Toll-like Receptors-mediated Pro-inflammatory Responses in Microglia and Astrocytes", Experimental Neurobiology, 25(5), pp.262~268 (2016), 한국뇌신경과학회
35. Notter T, "Reconceptualization of translocator protein as a biomarker of neuroinflammation in psychiatry", Mol Psychiatry, 23, pp.36~ (2018)
36. Christensen A, "TSPO ligand PK11195improves Alzheimer-related outcomes in aged female 3xTg-AD mice", Neurosci Lett, 683, pp.7~12 (2018)
37. Gong J, "Translocator protein ligand protects against neurodegeneration in the MPTP mouse model of Parkinsonism", J Neurosci, 39, pp.3752~3769 (2019)
38. Daugherty DJ, "A TSPO ligand is protective in a mouse model of multiple sclerosis", EMBO Mol Med, 5, pp.891~903 (2013)
39. Verleye M, "The anxiolytic etifoxine activates the peripheral benzodiazepine receptor and increases the neurosteroid levels in rat brain", Pharmacol Biochem Behar, 82, pp.712~720 (2005)
40. Okuyama S, "Neuropharmacological profile of peripheral benzodiazepine receptor agonists, DAA1097 and DAA1106", Life Sci, 64, pp.1455~1464 (1999)
41. Wang D-s, "Anxiolytic-like effects of translocator protein(TSPO)ligand ZBD-2 in an animal model of chronic Pain", Mol Pain, 11, pp.16~ (2015)
42. Da Pozzo E, "Targeting the 18-kDa translocator protein : recent perspectives for neuroprotection", Biochem Soc Trans, 43, pp.559~565 (2015)
43. Kim EJ, "Translocator protein 18 kDa(TSPO) : old dogma, new mice, new structure, and new questions for neuroprotection", Neural Regen Res, 10, pp.878~ (2015)
44. Kupa LdVK, "Role of Translocator 18 KDa Ligands in the Activation of Leukotriene B4 Activated G-Protein Coupled Receptor and Toll Like Receptor-4Pathways in Neutrophils", Front Pharmacol, 8, pp.766~ (2017)
45. Lee JW, "A translocator protein 18 kDa ligand, Ro5-4864, inhibits ATP-induced NLRP3 inflammasome activation", Biochem Biophys Res Comm, 474, pp.587~593 (2016)
46. Wang W, "Lentiviralmediated overexpression of the 18 kDa translocator protein(TSPO)in the hippocampal dentate gyrus ameliorates LPS-induced cognitive impairment in mice", Front Pharmacol, 7, pp.384~ (2016)
47. Bae KR, "Translocator protein 18 kDa negatively regulates inflammation in microglia", J Neuroimmune Pharmacol, 9, pp.424~437 (2014)
48. Wang M, "Macrogliamicroglia interactions via TSPO signaling regulates microglial activation in the mouse retina", J Neurosci, 34, pp.3793~3806 (2014)
49. Deczkowska A, "Targeting neuro–immune communication in neurodegeneration : Challenges and opportunities", J Exp Med, 215, pp.2702~2704 (2018)
50. Schwartz M, "Can immunotherapy treat neurodegeneration?", Science, 357, pp.2017~ (2017)
51. Notter T, "Translational evaluation of translocator protein as a marker of neuroinflammation in schizophrenia", Mol Psychiatry, 23, pp.323~ (2018)
52. Owen DR, "Proinflammatory activation of primary microglia and macrophages increases 18 kDa translocator protein expression in rodents but not humans", J Cereb Blood Flow Metab, 37, pp.2679~2690 (2017)
53. Daugherty DJ, "The hGFAP-driven conditional TSPO knockout is protective in a mouse model of multiple sclerosis", Sci Rep, 6, pp.22556~ (2016)
54. Milenkovic VM, "CRISPR-Cas9Mediated TSPO Gene Knockout alters Respiration and Cellular Metabolism in Human Primary Microglia Cells", Int J Mol Sci, 20, pp.3359~ (2019)
55. md. Maqusood Alam, "Recent Progress in the Development of TSPO PET Ligands for Neuroinflammation Imaging in Neurological Diseases", Nuclear Medicine and Molecular Imaging, 51(4), pp.283~296 (2017), 대한핵의학회
56. PK11195, "Eur J Neurol", 2003, 257~264
57. Cagnin A, "In-vivo measurement of activated microglia in dementia", The Lancet, 358, pp.461~467 (2001)
58. (R)-PK11195 PET in idiopathic Parkinson's disease, "Neurobiol Dis", 2006, 404~412
59. (R)-PK11195 positron emission tomography study, "Neurobiol Dis", 2004, 601~609
60. SSR180575, a novel indoleacetamide radioligand of the translocator protein(18 kDa), "Eur J Nucl Med Mol Imaging", 2011, 509~514
61. Li L, "The peripheral benzodiazepine receptor ligand 1-(2-chlorophenyl-methylpropyl)-3-isoquinoline-carboxamide is a novel antagonist of human constitutive androstane receptor", Mol Pharmacol, 74, pp.443~453 (2008)
62. Bordet T, "Identification and characterization of cholest-4-en-3-one, oxime(TRO19622), a novel drug candidate for amyotrophic lateral sclerosis", J Pharmacol Exp Ther, 322, pp.709~720 (2007)
63. Schaller S, "TRO40303, a new cardioprotective compound, inhibits mitochondrial permeability transition", J Pharmacol Exp Ther, 333, pp.696~706 (2010)
64. Nguyen N, "Efficacy of etifoxine compared to lorazepam monotherapy in the treatment of patients with adjustment disorders with anxiety : a double-blind controlled study in general practice", Hum Psychopharmacol, 21, pp.139~149 (2006)
65. do Rego JL, "The nonbenzodiazepine anxiolytic drug etifoxine causes a rapid, receptor-independent stimulation of neurosteroid biosynthesis", PLoS One, 10, pp.e0120473~ (2015)
66. Rupprecht R, "Translocator protein(18 kD)as target for anxiolytics without benzodiazepine-like side effects", Science, 325, pp.490~493 (2009)
67. Biswas L, "TSPO Ligands Promote Cholesterol Efflux and Suppress Oxidative Stress and Inflammation in Choroidal Endothelial Cells", Int J Mol Sci, 19, pp.3740~ (2018)
68. Tu LN, "Peripheral benzodiazepine receptor", translocator protein global knockout mice are viable with no effects on steroid hormone biosynthesis, 2014, pp.289, 27444~27454
69. Morohaku K, "Translocator protein", peripheral benzodiazepine receptor is not required for steroid hormone biosynthesis, 2014, pp.155, 89~97
70. Šileikytė J, "Regulation of the mitochondrial permeability transition pore by the outer membrane does not involve the peripheral benzodiazepine receptor(Translocator Protein of 18 kDa(TSPO))", J Biol Chem, 289, pp.13769~13781 (2014)
71. Zhao AH, "Mitochondrial translocator protein(TSPO)function is not essential for heme biosynthesis", J Biol Chem, 291, pp.1591~1603 (2016)
72. Tu LN, "PK11195 effect on steroidogenesis is not mediated through the translocator protein(TSPO)", Endocrinology, 156, pp.1033~1039 (2015)
73. Hatty CR, "Investigating the interactions of the 18 kDa translocator protein and its ligand PK11195 in planar lipid bilayers", Biochim Biophys Acta Biomembr, 1838, pp.1019~1030 (2014)
74. Bader S, "Differential effects of TSPO ligands on mitochondrial function in mouse microglia cells", Psychoneuroendocrinology, 106, pp.65~76 (2019)

관련 논문AI추천